Brief: Naya Biosciences Announces Development Of NY-500

INVO Fertility

06/01/2025 14:47

Jan 6 (Reuters) - NAYA Biosciences Inc  NAYA.O :
    * NAYA BIOSCIENCES ANNOUNCES DEVELOPMENT OF NY-500, A NOVEL
AI-OPTIMIZED PD-1 X VEGF BIFUNCTIONAL ANTIBODY
    * NAYA BIOSCIENCES INC - TO INITIATE CLINICAL TRIALS IN
EARLY 2026
    * NAYA BIOSCIENCES INC - NY-500 EXPECTED TO ENTER PHASE 1/2A
TRIALS IN EARLY 2026
    * NAYA BIOSCIENCES INC - PHASE 1/2A CLINICAL TRIALS EXPECTED
TO
START IN 2025

Source text:  urn:newsml:reuters.com:*:nGNXbgY01Y
Further company coverage:  NAYA.O 

 ((Reuters.Briefs@thomsonreuters.com;))